FDCDDQ
KNSA icon

Federation des caisses Desjardins du Quebec’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.4K Buy
710
+210
+42% +$10.9K ﹤0.01% 1955
2026
Q1 		$24.1K Hold
500
– – ﹤0.01% 2061
2025
Q4 		$20.6K Hold
500
– – ﹤0.01% 2048
2025
Q3 		$19.4K Buy
+500
New +$16.2K ﹤0.01% 2053
2025
Q2 		– Sell
-42,313
Closed -$940K – 2791
2025
Q1 		$940K Buy
42,313
+28,307
+202% +$583K ﹤0.01% 845
2024
Q4 		$277K Buy
+14,006
New +$320K ﹤0.01% 1083

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Federation des caisses Desjardins du Quebec's KNSA Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Kiniksa Pharmaceuticals (KNSA) stake by 42% in Q2 2026, buying an estimated $10.9K and bringing the position to 710 shares worth $45.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1955.

Federation des caisses Desjardins du Quebec first reported a position in KNSA in Q4 2024 and has held it in 6 quarters since. The position peaked at $940K in Q1 2025. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 710 shares of Kiniksa Pharmaceuticals worth $45.4K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 210 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $10.9K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1955 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Kiniksa Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Federation des caisses Desjardins du Quebec's Kiniksa Pharmaceuticals position peaked at $940K in Q1 2025.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.